Recombinant multi-species CCDC23/SVBP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCDC23/SVBP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables microtubule binding activity. Involved in axon development; proteolysis; and regulation of metallopeptidase activity. Acts upstream of or within negative regulation of endothelial cell migration; negative regulation of protein ubiquitination; and protein secretion. Located in apical part of cell. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: 2410005K17Rik,CCDC23,Ccdc23,Coiled coil domain-containing protein 23,NEDAHM,RGD1311232,SVBP,Small vasohibin-binding protein,Svbp

Target products collectionGo to CCDC23/SVBP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1327-Ag-1/ GM-Tg-hg-SE1327-Ag-2 Human CCDC23/SVBP protein Human
GM-Tg-rg-SE1327-Ag-1/ GM-Tg-rg-SE1327-Ag-2 Rat CCDC23/SVBP protein Rat
GM-Tg-mg-SE1327-Ag-1/ GM-Tg-mg-SE1327-Ag-2 Mouse CCDC23/SVBP protein Mouse
GM-Tg-cynog-SE1327-Ag-1/ GM-Tg-cynog-SE1327-Ag-2 Cynomolgus/Rhesus macaque CCDC23/SVBP protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1327-Ag-1/ GM-Tg-felg-SE1327-Ag-2 Feline CCDC23/SVBP protein Feline
GM-Tg-cang-SE1327-Ag-1/ GM-Tg-cang-SE1327-Ag-2 Canine CCDC23/SVBP protein Canine
GM-Tg-bovg-SE1327-Ag-1/ GM-Tg-bovg-SE1327-Ag-2 Bovine CCDC23/SVBP protein Bovine
GM-Tg-equg-SE1327-Ag-1/ GM-Tg-equg-SE1327-Ag-2 Equine CCDC23/SVBP protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1327-Ag-1/ GM-Tg-hg-SE1327-Ag-2; GM-Tg-rg-SE1327-Ag-1/ GM-Tg-rg-SE1327-Ag-2;
GM-Tg-mg-SE1327-Ag-1/ GM-Tg-mg-SE1327-Ag-2; GM-Tg-cynog-SE1327-Ag-1/ GM-Tg-cynog-SE1327-Ag-2;
GM-Tg-felg-SE1327-Ag-1/ GM-Tg-felg-SE1327-Ag-2; GM-Tg-cang-SE1327-Ag-1/ GM-Tg-cang-SE1327-Ag-2;
GM-Tg-bovg-SE1327-Ag-1/ GM-Tg-bovg-SE1327-Ag-2; GM-Tg-equg-SE1327-Ag-1/ GM-Tg-equg-SE1327-Ag-2
Products Name CCDC23/SVBP protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CCDC23/SVBP
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCDC23/SVBP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.